Skip to content

C80.2

Billable

Malignant neoplasm associated with transplanted organ

HCC Category Mapping

V28HCC 23Melanoma and Other Skin Cancers
0.251
V24HCC 12Breast, Prostate, and Other Cancers and Tumors
0.150
ESRDHCC 12Breast, Prostate, and Other Cancers and Tumors
0.000
RxHCCHCC 22Cancer, Other Specified Sites
0.000

What This Code Means

Cancer that develops in an organ that was transplanted into a patient from a donor.

Coding Tips

  • Document the type of transplanted organ and the cancer type when possible
  • This code indicates post-transplant malignancy; coordinate with transplant history in medical record

Clinical Significance

Malignant neoplasm associated with transplanted organ captures cancers that develop in or are directly related to organ transplantation, including donor-transmitted malignancies and post-transplant lymphoproliferative disorder (PTLD). Transplant recipients have a 2-4 fold increased cancer risk due to chronic immunosuppression, and these malignancies often behave more aggressively. This diagnosis requires careful coordination between oncology and transplant teams regarding immunosuppression management.

Documentation Requirements

  • Documentation that the malignancy is associated with or arose in a transplanted organ
  • Type of transplant (kidney, liver, heart, lung, etc.) coded separately with Z94 codes
  • Specific cancer type if identifiable (code additionally if possible)
  • Current immunosuppression regimen and any modifications made due to the malignancy
  • Whether the cancer was donor-transmitted or developed de novo post-transplant
  • Duration since transplant to cancer diagnosis

Use Additional Code

  • code to identify the specific malignancy

Code First

  • complication of transplanted organ (T86.-)

Commonly Confused Codes

Code Hierarchy

Open C80.2 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.